EpistrySign in
LimitedMetadata only — full assessment not yet run

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Antonio Cuadrado, Gina Manda, Ahmed Hassan, María José Alcaraz, Coral Barbas, Andreas Daiber, Pietro Ghezzi, Rafael León, Manuela G. López, Baldo Oliva, Marta Pajares, Ana I. Rojo, Natalia Robledinos-Antón, Ángela M. Valverde, Emre Güney, Harald Schmidt · Pharmacological Reviews · 2018

DOI 10.1124/pr.117.014753

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-08-23).
  • Designjournal article
    • Journal article (Pharmacological Reviews). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationhighly cited
    • Cited by 624 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in Pharmacological Reviews.
    • Publisher: American Society for Pharmacology and Experimental Therapeutics.
    • ISSN 0031-6997.
    • The journal is not listed in DOAJ.
    • Open-access status: bronze.
Assessed by Epistry · metadata as of August 23, 2026
Transcription Factor NRF2 as a Therapeutic Target for Chronic Disease… — Epistry